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Cervical cancer
HPVPV) 16 is a DNA virus encoding three oncogenes — E5, E6, and E7. The E6 and E7
proteins have well-established roles as inhibitors of tumor suppression, but the contribution of E5 to
malignant transformation is controversial. Using spontaneously immortalized human keratinocytes (HaCaT
cells), we demonstrate that expression of HPV16 E5 is necessary and sufﬁcient for the formation of bi-
nucleated cells, a common characteristic of precancerous cervical lesions. Expression of E5 from non-
carcinogenic HPV6b does not produce bi-nucleate cells. Video microscopy and biochemical analyses reveal
that bi-nucleates arise through cell–cell fusion. Although most E5-induced bi-nucleates fail to propagate, co-
expression of HPV16 E6/E7 enhances the proliferation of these cells. Expression of HPV16 E6/E7 also
increases bi-nucleated cell colony formation. These ﬁndings identify a new role for HPV16 E5 and support a
model in which complementary roles of the HPV16 oncogenes lead to the induction of carcinogenesis.
© 2008 Elsevier Inc. All rights reserved.IntroductionPrior infection with human papillomavirus (HPV), a small, non-
enveloped DNA virus, is strongly associated with the development of
cervical cancer, anogenital cancer, and certain proliferative disorders
(Bosch et al., 2002). Of the approximately 120 types of HPV, thirteen
(HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66) have been
designated as “carcinogenic” by the International Agency for Research
on Cancer (IARC) (Cogliano et al., 2005). Of these carcinogenic HPVs,
HPV16 is the most prevalent and is detected in 57.6% of cervical
cancers (Munoz et al., 2004). Despite the clear association between
cervical cancer and HPV, the sequence of molecular events that follow
HPV infection and lead to cervical cell transformation remain to be
deﬁned.
The ∼8000 base pair HPV genome is comprised of 8 genes. Three of
these, early genes, E5, E6, and E7 have been shown to be oncogenic. E6
and E7 inhibit the function of the tumor suppressors p53 and Rb,
respectively (Jones et al., 1997; Werness et al., 1990). Expression of E6
or E7 enables cells to bypass normal cell cycle checkpoints and allows
uncontrolled replication of cervical cells persistently infected withmagglutinin; tTA, tetracycline
with tTA; FACS, Fluorescence
niversity of Oklahoma Health
medical Sciences Building, Rm
548.
).
l rights reserved.HPV. This process enables cells to accumulate additional genomic
aberrations, but is not thought to be directly responsible (Incassati et
al., 2006; Plug-DeMaggio et al., 2004). It has been suggested that the
development of genomic instability is secondary to inhibition of cell
cycle checkpoint regulators (Duensing and Munger, 2002).
The third oncogenic protein of the HPV genome, E5, is sufﬁcient to
transform mouse ﬁbroblasts and keratinocytes in culture, as assessed
by anchorage independent growth and colony formation assays
(Leechanachai et al., 1992; Pim et al., 1992; Straight et al., 1993). Co-
expression of E5 with either E6 or E7 potentiates the transforming
properties of either protein alone (Bouvard et al., 1994; Stoppler et al.,
1996; Valle and Banks, 1995). However, the mechanism by which E5
participates in transformation is unclear. The diverse functions
proposed for E5 include protecting the cell against apoptosis (Kabsch
and Alonso, 2002; Zhang et al., 2002), interfering with cell–cell
communication (Oelze et al., 1995), and inhibition of antigen
presentation in infected cells (Zhang et al., 2003). However, the
most commonly accepted model is that the E5 gene product
potentiates the signaling of the epidermal growth factor receptor
(EGFR) by slowing EGFR endocytic trafﬁcking and degradation
(Straight et al., 1993, 1995; Zhang et al., 2005). Identifying a molecular
role for E5 in infected tissues has been difﬁcult due to its low level of
protein expression, rare integration of the E5 gene into the host
chromosome, and a lack of reagents, antibodies, and animal models
(Conrad et al., 1994; Disbrow et al., 2005; Oelze et al., 1995; Oetke et
al., 2000; Straight et al., 1995). The scarcity of data due to these
technical difﬁculties has impeded the generation of a deﬁnitive model
for E5 function.
Fig. 1. Expression of the wild type HPV16 genome, but not HPV16 with an E5 frameshift
mutation, causes the formation of bi-nucleated cells. (A) HaCaT cells were co-
transfected with 2 μg of pEGFP-C1 and 2 μg of linearized WT HPV16 or HPV16 E5 fs
by nucleofection. Following recovery of the cells (72 h), cells were ﬁxed, stained with
DAPI, and examined by ﬂuorescent microscopy. Shown are representative images of
DAPI stained nuclei, GFP-positive (transfected) cells, and the merger of the two images.
Arrow indicates a bi-nucleated cell. Size bar=10 μm. (B) Quantiﬁcation of the
percentage of bi-nucleated cells (n=3). Data are plotted as the average±S.E.M. of
percentage of bi-nucleated cells following transfection with nothing, wild type HPV16,
or HPV16 with an E5 frameshift mutation. ⁎ indicates p-valueb0.01 (two tailed
student's t-test) (C). Cell lysates from the experiment described in A were collected,
resolved by 16% Tris–tricine gel, and immunoblotted for HPV16 E7 (Zymed).
126 L. Hu et al. / Virology 384 (2009) 125–134In this report, we examine the effect of HPV16 E5 expression in
human keratinocytes, the cell type transformed in vivo by HPV16.
Expression of HPV16 E5 causes the formation of bi-nucleated cells by
inducing cell–cell fusion. Normally, intrinsic cell cycle checkpoints
prevent propagation of bi-nucleated cells. However, expression of
HPV16 E6/E7 inhibits p53 and Rb, and thereby facilitates cell
proliferation and transformation. These data support a model in
which E5 plays a critical initiating role in the early stages of HPV-
induced cellular transformation.
Results
There are conﬂicting reports of HPV16 E5 function in the literature.
To better understand the role of HPV16 E5 in the context of the whole
virus, we expressed either the genome of wild type HPV16 (WT
HPV16) or HPV16 with a frame shift mutation in the E5 gene (HPV16
E5 fs) in HaCaT cells, a spontaneously immortalized human keratino-
cyte cell line (Boukamp et al., 1988). This frameshift mutant only
expresses the ﬁrst 11 amino acids of the protein, and this E5 fragment
is not a functional protein (Genther et al., 2003). There were striking
differences in the cell morphology following expression of WT HPV16
and HPV16 E5 fs (Fig. 1A). Cells expressing WT HPV16 had more than
three times the number of bi-nucleated cells as those expressing
HPV16 E5 fs mutation (Fig. 1B) despite similar levels of the HPV16
genome being expressed (Fig. 1C).
To better study the function of HPV16 E5, we generated
tetracycline-regulatable adenoviruses that express hemagglutinin
(HA) tagged HPV16 E5. The cDNA encoding the HA epitope allows
detection of the exogenous HPV16 E5 since antibodies to HPV16 E5
itself are not available. To enhance protein expression, codons of the
HPV16 E5 cDNA were optimized to the tRNAs that are prevalent in
mammalian cells (Disbrow et al., 2003). The HA epitope was
engineered onto either the 5′ or 3′ end of the HPV16 E5 cDNA and
the resulting proteins were designated as HA-E5 and E5-HA,
respectively (Fig. 2A). HaCaT cells were stably transfected with the
tetracycline transactivator (tTA-HaCaT) to produce a “tet-off” system
(Gossen and Bujard, 1992). tTA-HaCaT cells were infected separately
with each E5-encoding adenovirus. Infection with either adenovirus
resulted in E5 protein expression in ∼90% of cells by 24 h post-
infection. The addition of tetracycline to infected cells abrogated
expression of the E5 protein (Fig. 2B) and served as a control for any
potentially deleterious effects of the adenovirus. This model system
allows the examination of the functional consequence of E5 expres-
sion for up to 96 h (Fig. 2C).
Expression of HPV16 E5 increases the percentage of bi-nucleated cells
Consistent with our observation following expression of the WT
HPV16 genome, expression of HPV16 E5 alone caused an increase in
bi-nucleated cells. The number of bi-nucleate cells increased 3-fold
within 72 h of E5 expression as compared to time-matched controls
(Fig. 3). Cells infected with adenovirus in the presence of tetracycline
to inhibit HA-E5 expression did not give rise to bi-nucleated cell, nor
did cells infected with a β-galactosidase encoding control adenovirus.
Similar increases in bi-nucleationwere seenwith expression of HPV16
E5-HA (data not shown).
To ensure that the increases in bi-nucleated cells were not a by-
product of adenovirus infection, we transfected cells with a plasmid
encoding HPV16 HA-E5. Bi-nucleate cells were formed in HaCaT cells
following transient transfection with plasmids encoding HA-E5
(pcDNA3-HA-E5), but not with the parental plasmid alone (Fig. 4).
To determine whether the increase in the percentage of bi-
nucleated cells was speciﬁc for HPV16 E5 or could arise following the
expression of E5 from any HPV, we examined the cell morphology of
HaCaT cells following expression of HPV6b E5. HPV6b is a non-
carcinogenic HPV, but its E5 protein contains a similar percentage of
Fig. 2. Expression of hemaggluttinin-tagged HPV16 E5 by adenovirus is tetracycline regulatable. (A) Hemaggluttinin (HA) tagged HPV16 E5 proteins used in this study. (B) Parental
HaCaT and tTA-HaCaT cells were uninfected or infected with the indicated adenoviruses (20 plaque forming units/cell) in the absence (−) or presence (+) of tetracycline (1 μg/ml).
Twenty-fours hours after infection, cell lysates (30 μg) were resolved on a 16% Tris–tricine gel and immunoblotted with the 12CA5 (anti-HA) mouse monoclonal antibody. (C) tTA-
HaCaT cells were infected with nothing, HA-E5, or E5-HA in the absence (−) or presence (+) of tetracycline (1 μg/ml). Cells lysates were collected at the indicated times post infection
(24, 48, 72, 96 h) and processed as in (B).
127L. Hu et al. / Virology 384 (2009) 125–134hydrophobic amino acids as the E5 from HPV16 (61% and 58%,
respectively) (Fig. 5A). The HPV6b E5, like the HPV16 E5, was codon-
optimized to enhance protein expression in mammalian cells. When
HaCaT cells were transfected with a plasmid encoding HPV6b E5
(pCDF1-HPV6b-HA-E5), the percentage of bi-nucleated cells was
comparable to cells transfected with empty plasmid (Figs. 5B, and
D), in contrast to HaCaT cells transfected with a plasmid encoding
HPV16 HA-E5 (pCDF1-HPV16 HA-E5) (Figs. 5B and D).
HPV16 E5 causes bi-nucleated cells by inducing cell–cell fusion
Cells can become bi-nucleated if they fail cytokinesis or by cell–cell
fusion. To determinewhether E5 caused aberrant cytokinesis, we used
video microscopy to monitor cells as they progressed through mitosis.
More than 40 cells expressing HPV16 E5 were ﬁlmed and all
underwent normal cytokinesis (data not shown). Thus, we concluded
that the bi-nucleate cells induced by E5 do not appear to be a
consequence of abortive cytokinesis.
However, during the live cell analysis, we observed HPV16 E5-
positive cells undergoing cell fusion (Supplemental Fig. 1). To quantify
the percentage of cells that fused, tTA-HaCaT cells were transfected
with a plasmid encoding Red Fluorescent Protein-tagged histone H2B
(pRK7-H2B-RFP). These cells were mixed with untransfected cells in a
1:1 ratio. The mixed culture was infected with an adenovirus
expressing HPV16 E5, and incubated for 24–72 h. At 24-hour intervals,
the cells were ﬁxed, permeabilized, and DAPI stained. Bi-nucleate cells
were analyzed by epiﬂuorescent microscopy for the presence of RFP-
H2B labeled and unlabeled nuclei. Bi-nucleate cells that arose due to
failed cytokinesis would contain two labeled or two unlabeled nuclei
as shown with cells whose cytokinesis is inhibited by treatment with
cytochalasin D (Fig. 6A) (or latrunculin B — data not shown). The
presence of heterokaryons, cells containing multiple, genetically
different nuclei, would indicate cell fusion. As a positive control for
cell fusion, we treated labeled and unlabeled cells with polyethyleneglycol (PEG 8000) (Fig. 6A). As seen in our video microscopy studies,
cells expressing HPV16 E5 gave rise to heterokaryons, indicating cell
fusion had occurred (Fig. 6A). At 72 h, 8.6% of all bi-nucleate cells were
heterokaryons (Fig. 6B).
The observed percentage of heterokaryons is signiﬁcantly less than
the predicted 1:2:1 ratio of unlabeled bi-nucleate cells:heterokaryons:
labeled bi-nucleate cells. However, data from cells that were fused by
PEG indicated that other factors are likely affecting cell fusion. One
explanation may be the transfection efﬁciency of H2B-RFP. Alterna-
tively, after a cell divides, the close proximity of the recently formed
daughter cells makes them more likely to fuse with one another.
Either event would skew the prediction of a 1:2:1 ratio that is based
on the assumption that each cell has an equal number of neighboring
labeled and unlabeled cells. Importantly, the inhibitors of cytokinesis,
latrunculin B (not shown) and cytochalasin D (Fig. 6B) produced no
heterokaryons.
As a third independent method of assessing whether cell fusion
occurred, we developed a quantiﬁable cell fusion assay. Using tTA-
HeLa cells, separate populations of cells were transfected with either a
plasmid encoding T7 RNA polymerase (pRK7-T7 RNA polymerase) or a
plasmid encoding yellow ﬂuorescence protein (YFP) driven by a T7
promoter (pT7-YFP). Only when the cells fuse together is the YFP
produced. Using this assay, we are able to monitor the formation of
fused cells over time as well as rapidly quantify the number of YFP-
positive cells by FACS.
In cells that express HPV16 HA-E5, there is an increase in the
percentage of YFP positive cells as well as an increase in the mean
ﬂuorescent intensity of those cells (see Supplemental Fig. 2). Shown
in Fig. 6C, there is a 7-fold increase in total YFP production (per-
centage of YFP positive cells multiplied by mean ﬂuorescent
intensity) as compared to cells that were uninfected, infected with
HPV16 HA-E5 in the presence of tetracycline, or infected with a
control β-galactosidase adenovirus. These experiments corroborate
the video microscopy ﬁndings (Supplemental Fig. 1) and conﬁrm the
Fig. 4. Transfection of cells with HA-E5 causes an increase in the percentage of bi-
nucleate cells. A plasmid encoding HA-E5 under the direction of a CMV promoter
(pcDNA3-HA-E5) or empty vector (pcDNA3) was introduced into cells by nucleofection
(Amaxa Biosystems, Gaithersburg, MD). (A) Transfected cells were ﬁxed and stained by
indirect immunoﬂuorescence using the 12CA5 antibodies and an Alexa488-labeled goat
anti-mouse secondary antibody. Cell nuclei are labeled with DAPI. Arrow indicates a bi-
nucleated cell. Size bar=10 μm (B). The percentage of HA-E5 transfected cells that are bi-
nucleate. Transfected cells that were ﬁxed and stained as in (A) were scored for bi-
nucleation. Data are plotted as the average±S.E.M. from 3 experiments from at least 500
cells per experiment. ⁎p-valueb0.05 (two tailed, unpaired t-test) as compared to cells
transfected with empty vector.
Fig. 3. Expression of HPV16 E5 increases the percentage of bi-nucleate cells. (A) tTA-
HaCaT cells were infected with nothing or HA-E5 in the absence or presence of
tetracycline (tet) as indicated. Cells were ﬁxed and stained by indirect immunoﬂuor-
escence with the 12CA5 mouse monoclonal antibody and nuclei were stained with
DAPI. Arrow indicates a bi-nucleated cell. Images were collected using Olympus AX70
epiﬂuorescent microscope with Q-Capture software. Size bar is 10 μm. (B) The per-
centage of bi-nucleate cells treated as in (A). Shown is the average percentage±S.E.M.
of bi-nucleate cells from three independent experiments (≥500 cells/experiment).
⁎ indicates a p-value of b0.05 (two-tailed, unpaired t-test) as compared to time-
matched cells infected in the presence of tetracycline.
128 L. Hu et al. / Virology 384 (2009) 125–134observation that HPV16 E5 is a fusogenic agent. Furthermore, these
data establish that the ability of HPV16 E5 to induce cell–cell fusion
is not restricted to HaCaT cells, as HPV16 E5 also induces the fusion
of HeLa cells.
Most bi-nucleated cells fail to propagate.
Cell–cell fusion has been proposed as an initiator of carcinogenesis,
and is a feature of many oncogenic viruses (Duelli and Lazebnik,
2007). Models implicating a role for cell–cell fusion in carcinogenesis
suggest that the vast majority of the bi-nucleated cells that arise from
cell–cell fusion become quiescent or apoptotic. Those that escape cell
cycle arrest or cell death and replicate, have an increased propensity to
become aneuploid, presumably because the cell is not equipped for
processing twice the normal number of chromosomes and over time
segregation errors occur. The likelihood of these errors to go
undetected is enhanced when cell cycle checkpoints are disrupted.
To determine if the bi-nucleated cells that formed in response to
HPV16 E5 expression acted in accordance with these models, we
monitored cell viability and transformation. Using our YFP-reporter
assay, cells that had undergone cell–cell fusionwere collected by FACS,
re-plated in growth media, and were assayed for cell viability by an
MTT assay (Fig. 7A). In contrast to the parental, mono-nucleated
HaCaT cells that grew 3-fold over 72 h, there was a reduced viability of
bi-nucleated cells. Bi-nucleated cell viability increased slightly ifexpression of HPV16 HA-E5 was ablated after cell–cell fusion by the
addition of tetracycline. We inhibited expression of HPV16 E5 because
there are numerous reports in the literature that its expression is
transient (Pater and Pater, 1985; Schwartz et al., 1985; Stoler et al.,
1992). To assess the contribution of other HPV16 oncogenes, we co-
transfected the cells with p1321 HPV-16 E6/E7, a plasmid that
expresses HPV16 E6/E7 from the human β-actin promoter (Munger
et al., 1989). HPV16 E6/E7 impede cell cycle checkpoint inhibitors (p53
and Rb) and permit propagation of cells that would otherwise be
growth arrested. Bi-nucleated cells that no longer express HPV16 HA-
E5, but do express HPV16 E6/E7 hadmore viable cells than the original
plating density, but this cell growth was not statistically signiﬁcant.
To determine whether fused cells had an increased propensity to
be transformed, we monitored the ability of cells to form colonies on
plastic, a measure of cell transformation (Liu et al., 2000). Ablation of
HPV16 HA-E5 in concert with continual expression of HPV16 E6/E7
produced three times the number of colonies observed with
constitutive HPV16 HA-E5 expression (Fig. 7B). In the absence of
HPV16 E6/E7, colony growth was not affected by the continual
presence of HPV16 HA-E5. Colonies that formed were comprised
primarily, although not exclusively, of mono-nucleated cells (Fig. 7C).
This indicates that the bi-nucleated phenotype can be lost with cell
division.
Together, these data provide evidence that while most bi-
nucleated cells formed as the result of HPV16 E5 expression cannot
Fig. 5. Expression of the E5 protein from a non-carcinogenic HPV does not cause an increase in the percentage of bi-nucleate cells. (A) Single letter amino acid code representation of
the sequences of the E5 proteins from HPV16 (Seedorf et al., 1985) and HPV6b (Schwartz et al., 1983). Hydrophobic amino acids are highlighted in grey. (B) Shown are representative
micrographs from HaCaT cells transfected with empty vector (pCDF1-MCS2-EF1-copGFP — subsequently referred to as pCDF1), the HA-tagged HPV6b E5, or HA-tagged HPV16 E5.
After transfection (48 h), the cells were ﬁxed, subjected to indirect immunoﬂuorescence using the 12CA5 (anti-HA) antibody and Alexa568-goat anti-mouse secondary antibody (red)
to indicate the presence of the HA-tagged E5 protein. Nuclei were stained with DAPI (blue). Cells transfected with empty vector are green, indicating the expression of the pCDF1
associated green ﬂuorescent protein (GFP). Arrow indicates a bi-nucleated cell. Size bar=10 μm. (C) Cells were transfected as in (B). Cell lysates were prepared and quantitatively
immunoprecipitated using the 12CA5 antibody. Immunoprecipitates were resolved by SDS-PAGE and immunoblotted with the 12CA5. Total starting materials was probed with an
anti-α-tubulin antibody (Sigma) to indicate amounts of starting material. (D) The percentage of bi-nucleated cells was calculated from cells transfected as in (B). The average
percentage of bi-nucleate cells±S.E.M. from N200 cells/experiment is plotted (n=3). N.S. indicates the data are not signiﬁcantly different compared to vector control. ⁎ indicates a p
valueb0.01 compared to vector control (two-tailed, unpaired t-test).
129L. Hu et al. / Virology 384 (2009) 125–134proliferate, the coordinated expression of HPV16 E6/E7 promotes
some cells to overcome the barriers of quiescence and/or apoptosis
and lead to cell transformation.
Discussion
Although it is widely held that particular types of HPV are the
causative agents of cervical carcinoma, a major unresolved issue in the
molecular etiology of this disease has been the role and contribution
of the virally-encoded E5 protein. In the work reported here, we have
identiﬁed a novel function for HPV16 E5 as an inducer of cell fusion.
Importantly, we provide corroborating evidence for how this
fusogenic property of E5 cooperates with HPV16-encoded E6 and E7
to promote the initiation of cell transformation. In addition, we
provide a cellular rationale for how the transient and limited E5
expression observed in patient samples could promote carcinogenesis.HPV16 E5 forms of bi-nucleated cells that do not form with
expression of E5 from the non-oncogenic, HPV6b E5. Three indepen-
dent lines of evidence establish that HPV16 E5 causes bi-nucleate cell
formation by inducing cell–cell fusion. First, live-cell videomicroscopy
reveals HPV16 E5 expressing cells can fuse and bi-nucleate cell
formation did not result from abortive cytokinesis (Supplemental Fig.
1). Second, using a heterokaryon fusion assay inwhich a population of
cells expressing RFP-H2B was mixed with a population of unlabeled
cells, we observed the presence of bi-nucleate cells containing
differentially-labeled nuclei (Figs. 6A and B). Third, using a ﬂuorescent
reporter assay inwhich the expression of YFP could only be detected if
a cell transfected with a plasmid encoding T7 RNA polymerase fused
with a cell transfected with a plasmid encoding YFP under the control
of the T7 promoter. Only mixed populations of cells expressing HPV16
E5 produced YFP (Fig. 6C). Consistent with all of this cell fusion data,
we also found that bi-nucleated cells were producedwith greater than
130 L. Hu et al. / Virology 384 (2009) 125–134a 3-fold frequency upon introduction of the intact HPV16 genome into
HaCaT cells as compared to cells transfected with an HPV16 genome
harboring a mutant E5 gene encoding a truncated, nonfunctional E5
protein.
Cell–cell fusion in biology and pathology
Cell–cell fusion has been reported to occur naturally during a
number of developmental processes (i.e. skeletal and cardiac muscles)
(Chen and Olson, 2005). Recently, there has been increased interest in
the role of cell–cell fusion in oncogenesis, particularly fusogenic
events mediated by viruses. Many oncogenic viruses, such as Hepatitis
B virus, Hepatitis C virus, Karposi sarcoma virus, and Epstein–Barr
virus, mediate cell–cell fusion and this fusogenic activity has been
posited to be a key initiating event in the development of cancer
(Duelli and Lazebnik, 2007). The fact that the carcinogenic HPV16
encodes a protein that causes cell–cell fusion is not entirely surprising,
although the assignment of this role to E5 is novel. Further, this ﬁnding
correlates well with the presence of bi-nucleated cells in pre-
cancerous cervical lesions (Mittal et al., 1990; Prasad et al., 1993).
HPV16 E5 has many of the features common to fusogenic proteins.
It is a class I integral membrane proteins with a high degree of
hydrophobicity, and can undergo oligomerization (Gieswein et al.,
2003; Martin and Ryuysschaert, 2000). Hydropathy proﬁles of the E5
gene products from all HPVs reveal that the proteins can be
phylogenetically and biochemically divided into four major groups
(E5α, β, δ, and γ) (Bravo and Alonso, 2004). The E5 proteins from all 13
carcinogenic HPVs belong to the E5α group that shares the common
structure of three hydrophobic domains. HPV16 E5 is comprised of
three hydrophobic stretches of 15–22 amino acids, although only the
ﬁrst is predicted to be long enough to span the plasma membrane. In
contrast, HPV6b E5 is a member of the E5γ group, and has two longer
hydrophobic stretches (30 and 40 amino acids each). For HPV16 E5,
the carboxyl and amino termini are hydrophilic, and thought not to be
associated with the plasmamembrane, although the exact orientation
is not known (Nath et al., 2006). Immunoﬂuorescence analysis of non-
permeabilized cells revealed that HPV16 E5 localizes to the plasma
membrane1. Given the data indicating that HPV16 E5 can mediate
cell–cell fusion, the three hydrophobic domains may be a necessary
structural feature that confers fusogenic properties to E5s. Consistent
with the idea that there is a structural component to HPV16 E5
mediated cell fusion is the observation that the comparably hydro-
phobic, but structurally distinct, HPV6b E5 does not cause cell–cell
fusion.
Role for cell fusion in HPV-mediated carcinogenesis
E5 expression is believed to be transient and limited following the
infection of cervical epithelium by HPV. This notion stems from the
kinetics of E5 mRNA levels in tissue samples and the observation that
E5 expression is not observed in malignant cervical tumors (Schwartz
et al., 1985; Stoler et al., 1992). The failure of the HPV16 E5 gene to
integrate into the host cell's genome (Schwartz et al., 1985) suggests
sustained expression of E5 is not necessary. Finally, numerous HPV-
positive cell lines fail to generate E5 mRNA at detectable levels (Pater
and Pater, 1985; Schwartz et al., 1985). Of note, E5 mRNA is the best
estimate of E5 expression given the absence of antibodies to detect the
protein. These observations coupled to our novel ﬁndings that E5 is a
fusogen (Figs. 6 and 7) and that sustained E5 expression compromises
cell viability (Fig. 7), have led to ourmodel that transient E5 expression
favors cellular transformation whereas sustained E5 expression likely
leads to multiple cell fusion events and cell death (Fig. 7). Thus, our
data provide the ﬁrst experimental rationale for transient expression
of E5 that apparently occurs in HPV-infected patients.1 L. Hu and B. Ceresa, data not shown.Experimental evidence for cell fusion contributing to carcinogen-
esis comes from a recent paper by Duelli et al. in which they
demonstrate that cell fusion is sufﬁcient to induce chromosomal
instability (Duelli et al., 2007). The authors show that if cell–cell fusion
occurs concomitantly with oncogene expression and cell cycle
deregulation, tumor formation can result. The authors speculate that
if such a fusogenic agent were expressed in the presence of HPV16 E6
and E7, that could explain how cervical cancer is induced.
Progression of an HPV-infected cell to a tumor is a rare event that
occurs over a long timeframe. Neoplastic progression is associated
with cells containing an abnormal complement of DNA and a
dysregulated cell cycle which enables them to divide despite their
detachment from basement membrane. Progression to fully evolved
cancer would require the accumulation of additional key abnormal-
ities; events that likely occur infrequently. Based on our data and
reports in the literature, we have developed the “hit and run” model
for the contribution of E5 to the initiation of tumorigenesis in the
context of an HPV infection. The salient features of this model are: (1)
cervical epithelial cells are infected with HPV and the HPV genome is
episomally maintained. (2) The “hit” — E5 mRNA levels peak and
expression of the E5 protein leads to cervical cell–cell fusion and the
accumulation of tetraploid and polyploid cells. (3) The resulting
genomic insult triggers the stabilization and activation of p53. (4) The
expression of E5 is downregulated — the “run”. (5) The expression of
E6 promotes the ubiquitin-dependent degradation of p53, thus
enabling the cells to overcome the gatekeeper function of p53
which functions to arrest genomically-compromised cells. (6) Expres-
sion of E7 blocks Rb thereby preventing terminal differentiation of the
infected epithelial cells. Collectively then, the expression of E5, E6, and
E7, produces cells that (i) have an abnormal amount of DNA due to
cell–cell fusion, (ii) are defective in cell cycle regulation, and (iii) are no
longer properly programmed to terminally differentiate.
Data presented in Fig. 7 support this model. By speciﬁcally
examining bi-nucleated cells derived following E5 expression, we
were able to assess the interplay of HPV16 E5, E6, and E7 on cell
viability and transformation. Under all conditions, bi-nucleated cells
fail to propagate over the course of 72 h (Fig. 7A), although cell viability
was increased by attenuating expression of HPV16 E5 or increasing
expression of HPV16 E6/E7. Although few bi-nucleated cells form
colonies, the likelihood for colony formation increases 3-fold when
expression of HPV16 HA-E5 is temporally regulated and the E6/E7
oncogenes are expressed. Further, the colonies that arise from these
bi-nucleated cells consist mainly of mono-nucleated cells indicating
the bi-nucleated cells can divide when HPV16 E6/E7 are present.
Unlike the other two HPV16 oncogenes, E6 and E7, which cause
unregulated cell proliferation, our ﬁndings indicate that E5 induces bi-
nucleated cell formation, a characteristic of cervical cancer. These
results support a role for HPV16 E5 inducing bi-nucleated cells that
may promote genomic instability in subsequent rounds of cell
division. These data provide the groundwork for a plausible mechan-
ism by which E5, E6 and E7 work in concert to increase the likelihood
of cellular transformation.
Materials and methods
Generation of tTA-HaCaT cells
HaCaT cells were retrovirally infected with the tetracycline
transactivator (tTA) (Clontech Retroviral GeneTransfer and Expression
System). Neomycin resistant colonies were grown in 800 μg/ml G418.
Individual colonies were isolated, ampliﬁed, and screened based on
their ability to regulate expression of tetracycline-regulatable adeno-
virus. tTA-HeLa cells were generously obtained from Dr. Sandra
Schmid (The Scripps Research Institute).
Parental HaCaTand tTA-HaCaTcells weremaintained in Dulbecco's
Minimal Essential Media (DMEM) supplemented with 10% fetal
131L. Hu et al. / Virology 384 (2009) 125–134bovine serum (FBS), 100 U/ml penicillin, 100 U/ml streptomycin, and
2 mM glutamine. tTA-HeLa cells were maintained in the same media
but with 5% FBS. Cells stably transfected with tTA were maintained in
400 μg/ml G418. All three cell lines weremaintained at 37 °C in 5% CO2.
Adenovirus generation/expression
Codon optimized HPV16 E5 was generated as previously described
(Disbrow et al., 2003). A hemagglutinin (HA) epitope (MEYDVPDYAH)
was engineered to be expressed on either the amino (HA-E5) or
carboxyl (E5-HA) terminus of the protein by PCR, making theappropriate modiﬁcation of stop codons. Adenoviruses were gener-
ated using Clontech Adeno-X™ Tet-off expression system. All
adenoviruses were sequenced at the DNA sequencing facility at the
Oklahoma Medical Research Foundation.
Plasmids and transfection
HA-tagged, codon optimized HPV6 and HPV16 E5 were generated
as described above and subcloned into either the pcDNA3 (Invitrogen)
or pCDF1-MCS2-EF2-copGFP (System Biosciences).
The wild type HPV16 genome and E5 frameshift mutation were
cloned into a pUC-18 plasmid for the replication and antibiotic
selection for puriﬁcation (Genther et al., 2003). Prior to transfection,
CsCl puriﬁed cDNA (10 μg) was digested with BamH1 to isolate the
HPV16 genome from the backbone plasmid and the result ∼8000 bp
DNA fragment was isolated by gel puriﬁcation. The HPV16 genome
(2 μg) alongwith GFP-neomycin (pEGFP-C1; Clontech) was introduced
into 2×106 HaCaT cells by nucleofection (Amaxa).
pRK7-T7 RNA polymerase was generated by using PCR primers to
clone T7 RNA polymerase from BL21 E. coli (primer pairs 5′ TTA CAT
TCT AGA ATG AAC ACG ATT AAC ATC GCT AAG- 3′ and 5′ATG TAA CTC
GAG TTA CGC GAA CGC GAA CGC GAA GTC CGA - 3′). The primers
incorporated XbaI and XhoI restriction enzyme sites. The resulting
PCR product was digested with XbaI and XhoI, and ligated into the
same sites in pRK7 (with a multiple cloning site that has been altered
to include an XhoI site) such that the genewas driven by the plasmid's
CMV promoter. The T7 promoter driving the expression of His6-S-
tagged Yellow Fluorescent Protein (YFP) in pET30 (Novagen) was
ampliﬁed using PCR primers that added Spe1 sites upstream of the T7
promoter and downstream of the t7 terminator. The PCR product was
digested with SpeI, and subcloned into the pRK7 that was digested
with SpeI and XbaI to remove the CMV promoter. The resulting
plasmid is referred to as pT7-YFP.
Cell lysates and Immunoblotting
Cell lysates were prepared as previously described (Dinneen and
Ceresa, 2004). Proteins were resolved on 16% Tris–tricine gels and
transferred to nitrocellulose. Antibodies were obtained from the indi-
cated sources: anti-HA (12CA5 antibody, Roche), α-tubulin (Sigma),
HPV16 E7 (Zymed). Proteins were visualized with enhanced chemi-
luminescence and documented using a UV Products Imaging system.
Indirect immunoﬂuorescence
Indirect immunoﬂuorescence was performed as previously des-
cribed (Dinneen and Ceresa, 2004). The 12CA5 antibody was used atFig. 6. Expression of HPV16 E5 causes cell fusion. (A) Equal numbers of tTA-HaCaT cells
were transfected by nucleofection (Amaxa Biosystems) with either nothing or pRK7-
histone2B-RFP and mixed together at a 1:1 ratio. After recovery (24 h), cells were either
infected with HA-E5 adenovirus or incubated with 50% polyethylene glycol (PEG 8000)
or 0.6 μg/ml cytochalasin D. After incubation (5 min for PEG treatment, 48 h for HA-E5
and cytochalasin (D), cells were ﬁxed, and stained with DAPI. Bi-nucleated cells were
analyzed by ﬂuorescent microscopy for the presence of heterokaryons. Shown are
representative images of bi-nucleate cells indicating the fusion of two different cell
populations in HA-E5 expressing cells and PEG treated cells. A failure of cytokinesis was
induced by treatment with cytochalasin D. All resulting bi-nucleated cells had similarly
labeled nuclei. Size bar=10 μm. (B) Graphical representation of the percentage of
heterokaryons in the population of bi-nucleate cells (n=2–3). The number of
heterokaryons per total bi-nucleated cells is indicated parenthetically in each bar. (C)
tTA-HeLa cells were transfected with either pRK7-T7 RNA polymerase or YFP under the
control of the T7 promoter (pT7-YFP), co-plated, infected with HPV16 HA-E5
adenovirus, incubated for 72 h, and analyzed for the presence of YFP by FACS (see
Materials and methods for details). Data indicate the fold increase in ﬂuorescence
intensity of the YFP-positive cells (calculated from the percentage of YFP positive cells
multiplied by the mean ﬂuorescent intensity) as compared to the ‘No virus’ control.
Shown are the mean±S.E.M. (n=3–5). ⁎pb0.05 (two-tailed, unpaired t-test). Repre-
sentative FACS data are shown in Supplemental Fig. 2.
Fig. 7. Bi-nucleated cells have increased colony formation in the presence of HPV16 E6/E7. tTA-HaCaT cells were transfected with pRK7-T7 RNA polymerase or pT7-YFP, mixed in a 1:1
ratio, and infected with HPV16 HA-E5 adenovirus. Some cells were co-transfected with p1321 HPV-16 E6/E7 (+E6/E7). After infection (72 h), YFP-positive, bi-nucleated cells were
collected by FACS and plated for MTT assay, colony formation assay, or cultured to collect cell lysate. Parental, mononucleated tTA-HaCaT cells were plated in parallel. To sustain
HPV16 HA-E5 expression (indicated by “yes”), cells were growth without tetracycline; to abrogate HPV16 HA-E5 expression (indicated by “no”), cells were grown with tetracycline.
(A) Cells were plated at 2500 cells/well of a 96-well dish (plating density is indicated with solid line) and grown for 72 h in growth media. Cell viability was measured by MTT assay.
Data are plotted as the average number of cells/well (n=4). ⁎ indicates pb0.05 in paired student's t-test. (B) Cells were plated at 500 cells/well of 6 well dish (6 wells/condition in each
assay). Cells were grown for 21 days with media changes every 3 days. Colonies were stained with methyl violet. Only colonies visible to the naked eye were counted (colonies
containedN100 cells/colony). Data are normalized to growth without tetracycline for each transfection condition. (n=6). ⁎ indicates pb0.01 using chi square analysis. (C)
Representative images of a colony at 4× and 10× magniﬁcation (size bar=100 μm). (D) Parallel dishes of cells were grown with and without tetracycline for 72 h. Cell lysates were
prepared, resolved on a 16% Tris–tricine gel, and immunoblotted for either HA-E5 (12CA5 antibody) or HPV16 E7. Since HPV16 E6 and E7 are driven by the same promoter on the same
plasmid, expression of HPV16 E7 was interpreted as expression of both HPV16 E6 and E7.
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anti-mouse (Molecular Probes) was used at a dilution of 1:250. Cells
were also stained with 10 ng/ml DAPI (Sigma). Images were
captured using Olympus AX70 epiﬂuorescent microscope with Q-
Capture software. Bi-nucleated cells were calculated as the number
of cells with two nuclei divided by the total cells.
Heterokaryon formation assay
tTA-HaCaT cells (2×106 cells) were transfected with pRK7-histone
2B-RFP (1.5 μg plasmid) by nucleofection using the Amaxa Nucleo-
fector I (transfection efﬁciency ≥50%). After 24 h recovery, cells were
mixed in a 1:1 ratio with untransfected cells and then infected with
HA-E5 adenovirus (20 pfu/cell) or treated with cytocholasin D or
latrunculin B. At 24-hour intervals, cells were ﬁxed and observed by
ﬂuorescence microscopy for bi-nucleated cells. As a positive control,
heterokaryons were induced by treatments with polyethylene glycol
for 5 min (Madan and DeFranco, 1993).
FACS analysis
Cells were ﬁxed in 70% ethanol, and incubated with 20 μg/ml
propidium iodide (Sigma) for 1 h at 37 °C. Cells were analyzed using aFACS Calibur (Becton Dickinson). The data from 10,000 cells/experi-
ment were analyzed using Modﬁt LT 2.0 software (Verity).
Video microscopy
Time-lapse phase-contrast images were collected using a Zeiss
Axiovert 200Mmicroscope equipped with a Hamanatsu ORCA camera
and processed with Metamorph Software (Molecular Devices) as
previously described (Potapova et al., 2006).
Cell fusion assay
tTA-HeLa cells were transfected by calcium phosphate with
either a plasmid expressing T7 RNA polymerase (pRK7-T7 RNA
polymerase) or yellow ﬂuorescent protein (YFP) driven by a T7
promoter (pT7-YFP). Following 16 h of recovery, cells were washed,
and replated with 200,000 cells of each population (1:1 ratio) into a
well of a 12-well dish. Cells were infected with adenovirus as
indicated in the ﬁgure legend using the method described above.
Seventy-two hours post-infection, cells were collected, washed in
PBS, and analyzed using a FACS Calibur (Benton Dickson) at the
OUHSC Flow and Imaging Cytometry Laboratory. The data from
N10,000 cells/experiment were analyzed using Modﬁt LT 2.0
133L. Hu et al. / Virology 384 (2009) 125–134software (Verity). Data were plotted as the relative increase in the
total percentage of YFP (percentage of positive cells multiplied by
their ﬂuorescent mean intensity) as compared to cells without virus
infection.
Cell viability and colon formation assays
Cells were transfected as described for the cell fusion assay or co-
transfected with p1321 HPV-16 E6/E7 plasmid (Addgene plasmid
8641) (Munger et al., 1989). Bi-nucleated, fused cells were isolated by
an Inﬂux Cell Sorter at the OUHSC Flow and Imaging Cytometry
Laboratory. For cell viability assays, cells were plated at a density of
2500 cells/well and grown in growth media with and without
tetracycline for 72 h. As a control, the parental tTA-HaCaT cells were
plated at the same density. Cell viability was monitored by MTT assay
as previously described (Hansen et al., 1989). Colony formation was
measured by plating cells at a density of 500 bi-nucleated cells/35mm
dish. Cells were maintained in growth media with and without
tetracycline for 21 days (media changed every three days), ﬁxed and
stained with methyl violet (Liu et al., 2000). Only cell clusters of
greater than 100 cells were considered colonies.
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